Welcome to SciSync
Alpha v1.3
A new platform innovatively aggregating the latest science news and research with AI-generated summaries and social features.
41,818 articles retrieved since June 2023
The SciSync Advantage
Learn how SciSync can keep you up to date in your research area of interest.
Aggregation
The latest articles in each discipline are collected from a curated selection of journals and news sites.
AI Integration
All articles are summarized by OpenAI’s ChatGPT platform, providing rapid insights.
Interaction
Discuss articles, receiving or offering novel insight in the built-in comments section that journals lack.
Latest articles retrieved by SciSync
Early Sun Exposure Tied to Lower MS Relapse Risk in Children
Prenatal and early life sun exposure is associated with a lower risk for relapse in childhood-onset …
Prevalence of erectile dysfunction as long-COVID symptom in hospitalized Japanese patients
Abstract Coronavirus disease-2019 (COVID-19) is associated with a wide range of post-acute sequelae.…
[News] Sharp increase in patients waiting months for urgent cancer treatment
The number of patients with cancer who are experiencing treatment delays has almost quadrupled in re…
[News] Opposition to proposed US bill deemed “Cancer Gag Act”
Activists in US farm states are stepping up their battle against proposed bills that would block leg…
[News] Global Platform for childhood cancer medicine access starts distributing drugs
On Feb 11, 2025, the Global Platform for Access to Childhood Cancer Medicines (known as the Global P…
ACTRIMS 2025: Anticipating New Directions in DMTs for RRMS
Dr Annalisa Morgan previews discussions on disease-modifying therapies, emerging treatments such as …
Trump Administration Review of Psych Meds Raises Concerns
The administration’s suggestion that psychotropic drugs pose a ‘threat’ to childre…
ACTRIMS 2025: Anticipating New Directions in DMTs for RRMS
Dr Annalisa Morgan previews discussions on disease-modifying therapies, emerging treatments such as …
Trial By Error: A Letter to Cochrane’s Editor-in-Chief
By David Tuller, DrPH This morning, I e-mailed the following letter to Dr Karla Soares-Weiser, Cochr…
Breakthrough discovery unveils potential treatment for hepatitis B
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is…
Understanding IBS and Food Intolerances: What You Need to Know
Learn how to identify triggers, phase in low-FODMAP diets, and other pearls for your patients with I…
Groundbreaking study shows potential of new mRNA vaccine to help fight tuberculosis
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pione…
Deep Nanometry reveals hidden nanoparticles
Researchers have developed Deep Nanometry, an analytical technique combining advanced optical equipm…
Promising new class of antimalarial drugs discovered
Epigenetic inhibitors as a promising new antimalarial intervention strategy? A new study identifies …
Researchers develop novel computational approach for identifying synergistic drug combinations
Researchers have developed a powerful computational tool, named iDOMO, to improve the prediction of …